Oral Pharmacotherapy for Male Sexual Dysfunction

A Guide to Clinical Management

  • Gregory A. Broderick

Part of the Current Clinical Urology book series (CCU)

Table of contents

  1. Front Matter
    Pages i-xii
  2. Rafael Carrion, Derek Bochinski, Nadeem Rahman, Tom Lue
    Pages 1-24
  3. Jonathan D. Schiff, John P. Mulhall
    Pages 25-42
  4. Harin Padma-Nathan
    Pages 65-83
  5. Culley C. Carson III
    Pages 85-107
  6. Ajay Nehra
    Pages 109-148
  7. Thorsten Reffelmann, Robert A. Kloner
    Pages 199-220
  8. Pierre Theuma, Vivian A. Fonseca
    Pages 221-236
  9. Hans-Martin A. Fritsche, Mustafa F. Usta, Wayne J. G. Hellstrom
    Pages 253-277
  10. Alvaro Morales, Jeremy P. W. Heaton
    Pages 279-299
  11. Jeremy P. W. Heaton, Alvaro Morales, Michael A. Adams
    Pages 301-322
  12. Ronald W. Lewis
    Pages 323-337
  13. Ridwan Shabsigh, Anne R. Davis, Aristotelis G. Anastasiadis, Nawras Makhsida, Grace Yan
    Pages 423-443

About this book

Introduction

With the advent of such oral drugs as Viagra®, Cialis®, and Levitra® for the treatment of erectile dysfunction (ED), the burden of first patient evaluation has fallen on the primary care provider. In Oral Pharmacotherapy for Male Sexual Dysfunction: A Guide to Clinical Management, highly experienced urologists and physician researchers review each aspect of male sexual dysfunction (interest, performance, and orgasm) and their implications for treatment. The authors address a wide variety of clinical issues, ranging from common medical risk factors for ED to the evaluation and management of men who have atypical presentations that require focused testing; from diabetic ED to the safety assessment of PDE inhibitors for cardiac patients; and from combination drug therapy for refractory patients to neuropharmacological therapies. Guidance is also provided for vacuum erection devices and surgical implants, the role of self-medication with dietary supplements, the management of post-prostatectomy ED, and the emerging pharmaceutical therapies for rapid ejaculation. On the pharmaceutical side, the authors summarize the pharmacology and development of PDE-type 5 inhibitors, review the preclinical data and 5 years of postmarketing data on Viagra®, examine the preclinical data on Levitra®, and discuss the design and conduct of US clinical trials of Cialis®.
Authoritative and informative, Oral Pharmacotherapy for Male Sexual Dysfunction: A Guide to Clinical Management clarifies for urologists, family physicians, and internists each of the diagnostic approaches to male sexual dysfunction, as well as the pharmacological strategies available for its safe and effective management.

Keywords

Internist assessment patients primary care quality safety

Editors and affiliations

  • Gregory A. Broderick
    • 1
  1. 1.Department of UrologyMayo Clinic College of MedicineJacksonville

Bibliographic information

  • DOI https://doi.org/10.1385/1592598714
  • Copyright Information Humana Press Inc. 2005
  • Publisher Name Humana Press
  • eBook Packages Medicine
  • Print ISBN 978-1-58829-451-7
  • Online ISBN 978-1-59259-871-7
  • About this book